2024 Annual Meeting | C172 - Epilepsy Therapy Update

��ɫ��

2024 Annual Meeting | C172 - Epilepsy Therapy Update

Date Wednesday 04/17/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Anteneh M. Feyissa, MD, MSc, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should become familiar with all currently approved antiseizure medications in the US and how to tailor each drug by etiology of epilepsy; be aware of all surgical modalities, including minimally invasive therapies; and become familiar with neuromodulatory devices for the treatment of epilepsy, including responsive neurostimulation and deep brain stimulation.

This program is supported in part by educational grants from Catalyst Pharmaceuticals, Inc. and LivaNova USA, Inc.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT	Introduction	Introduction Anteneh M. Feyissa, MD, MSc, FAAN
03:35 PM - 04:10 PM MDT	Speaker	Update on ASMs: Selection of Antiseizure Medication by Etiology Anteneh M. Feyissa, MD, MSc, FAAN
04:10 PM - 04:45 PM MDT	Speaker	Advances in Neuromodulation Therapy for Epilepsy Dileep R. Nair, MD
04:45 PM - 05:20 PM MDT	Speaker	What Is New in Epilepsy Surgery? Mohamad Koubeissi, MD, FAAN
05:20 PM - 05:30 PM MDT	Discussion	Questions & Answers Anteneh M. Feyissa, MD, MSc, FAAN, Mohamad Koubeissi, MD, FAAN, Dileep R. Nair, MD

Faculty Disclosures
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Mohamad Koubeissi, MD, FAAN	Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Dileep R. Nair, MD	Dr. Nair has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��